Quantum量子訊息有限公司
← 最新全球產業報告

Epistaxis Market

研究執行與發布:Coherent Market Insights · 發布日期 2026-04-03 · 152 頁
由量子訊息有限公司(Quantum Information)在台灣代理銷售與提供授權諮詢。

2026 年市場規模
USD 1.2 Bn
2033 年預估規模
USD 2.1 Bn
年複合成長率 CAGR
4.8%

以上數字由 Coherent Market Insights 於本報告中提出,量子訊息原樣引用。

出版商 Coherent Market Insights產業別 Medical Devices出版日期 2026-04-03頁數 152報告編號 CMI771

授權報價

Single User Price$4,500 USD
Enterprise License$10,000 USD
洽詢購買 申請 Sample
完整報告名稱與涵蓋範圍
Epistaxis Market, By Indication (Anterior Epistaxis and Posterior Epistaxis), By Product Type (Vasoconstrictors, Anesthetics, Antibiotic Ointments, and Cauterizing Agents), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, and Online Pharmacies), By Geography (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa)

報告摘要

Epistaxis, also known as nose bleeding, is a common clinical condition that results in loss of blood from the tissue lining of the nose. Epistaxis is usually classified as anterior or posterior epistaxis. Anterior epistaxis is defined as the bleeding from anterior septum of the nose, which is usually known as Kiesselbach plexus. Anterior epistaxis is also known as acute epistaxis and is the most commonly observed type of epistaxis that can be cured through various medical treatments. On the other hand, posterior nosebleeds originating from the back of nasal package, near the throat are a relatively less common clinical condition, as it may result in significantly large amount of blood loss. The posterior nosebleeds lead to massive blood loss and difficulty in breathing that may result in fatigue, paleness, and chest pain. However, most nosebleeds are rarely life threatening and are benign, self-limiting, spontaneous, but recurrent. Epistaxis can be caused due to various factors such as lack of humidity in the atmosphere that results in drying of mucosal tract, hypertension, nasal tumors, and also, due to consumption of certain drugs, smoking, and alcohol. Market Dynamics There has been a steady rise in incidence of heart-related disorders leading to hypertension and high blood pressure in the recent past. Hypertension is one of the major causes of epistaxis and the increase in its prevalence is expected to be one of the major factors driving growth of the global epistaxis market. For instance, according to the World Health Organization (WHO), in 2019, 1.13 billion people worldwide suffered from hypertension. Key features of the study • This report provides in-depth analysis of the global epistaxis market, market size (USD Bn), and compound annual growth rate (CAGR %) during the forecast period: 2026 – 2033, considering 2025 as the base year • It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market • This study also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, market trends, regional outlook, and competitive strategies adopted by key players operating in this market • It profiles key players in the global epistaxis market based on the following parameters–company overview, financial performance, product portfolio, geographical presence, key developments, and strategies • Key players covered as a part of this study include Smith & Nephew, Medline Industries, Inc., Bristol-Myers Squibb Pharma Company, Ciron Drugs, and King Pharmaceuticals, Inc. • Insights from this report would allow marketers and management authorities of companies to make informed decision with respect to future product launches, governmental initiatives, technological up-gradation, market expansion, and marketing tactics • The global epistaxis market report caters to various stakeholders in this industry, including investors, product manufacturers, distributors, and suppliers for global epistaxis market, research and consulting firms, new entrants, and financial analysts Market Segmentation • By Indication o Anterior Epistaxis o Posterior Epistaxis • By Product Type o Vasoconstrictors o Anesthetics o Antibiotic Ointments o Cauterizing Agents • By Distribution Channel o Hospital Pharmacies o Retail Pharmacies o Online Pharmacies • By Regional Insights o North America  U.S.  Canada o Latin America  Brazil  Argentina  Mexico  Rest of Latin America o Europe  Germany  U.K.  Spain  France  Italy  Russia  Rest of Europe o Asia Pacific  China  India  Japan  Australia  South Korea  ASEAN  Rest of Asia Pacific o Middle East  GCC Countries  Israel  Rest of Middle East o Africa  South Africa  North Africa  Central Africa • Key Players Insights o Smith & Nephew o Medline Industries, Inc o Bristol-Myers Squibb Pharma Company o Ciron Drugs o King Pharmaceuticals, Inc
目錄 Table of Contents
Table of Contents 1. Research Objectives and Assumptions o Research Objectives o Assumptions o Abbreviations 2. Market Overview o Report Description  Market Definition and Scope o Executive Summary  Market Snippet, By Indication  Market Snippet, By Product Type  Market Snippet, By Distribution Channel  Market Snippet, By Region o Coherent Opportunity Map (COM) 3. Market Dynamics, Regulations, and Trends Analysis o Market Dynamics  Drivers  Restraints  Market Opportunities o Industry Trend o Mergers and Acquisitions o Technology Overview o Regulatory Scenario o Epidemiology o New Product Approvals/Launches o PEST Analysis 4. Global Epistaxis Market, By Indication, 2026 – 2033, (USD Bn) o Introduction  Market Share Analysis, 2026, 2029, and 2033 (%)  Y-o-Y Growth Analysis, 2021-2033  Segment Trends o Anterior Epistaxis  Introduction  Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn) o Posterior Epistaxis  Introduction  Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn) 5. Global Epistaxis Market, By Product Type, 2026 – 2033, (USD Bn) o Introduction  Market Share Analysis, 2026, 2029, and 2033 (%)  Y-o-Y Growth Analysis, 2021-2033  Segment Trends o Vasoconstrictors  Introduction  Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn) o Anesthetics  Introduction  Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn) o Antibiotic Ointments  Introduction  Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn) o Cauterizing Agents  Introduction  Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn) 6. Global Epistaxis Market, By Distribution Channel, 2026 – 2033 (USD Bn) o Introduction  Market Share Analysis, 2026, 2029, and 2033 (%)  Y-o-Y Growth Analysis, 2021-2033  Segment Trends o Hospital Pharmacies  Introduction  Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn) o Retail Pharmacies  Introduction  Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn) o Online Pharmacies  Introduction  Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn) 7. Global Epistaxis Market, By Region, 2026 – 2033 (USD Bn) o Introduction  Market Share Analysis, 2026, 2029, and 2033 (%)  Y-o-Y Growth Analysis, 2021-2033  Regional Trends o North America  Market Size and Forecast, By Indication, 2026-2033, (USD Bn)  Market Size and Forecast, By Product Type, 2026-2033, (USD Bn)  Market Size and Forecast, By Distribution Channel, 2026-2033, (USD Bn)  Market Size and Forecast, By Country, 2026-2033, (USD Bn) o U.S. o Canada o Europe  Market Size and Forecast, By Indication, 2026-2033, (USD Bn)  Market Size and Forecast, By Product Type, 2026-2033, (USD Bn)  Market Size and Forecast, By Distribution Channel, 2026-2033, (USD Bn)  Market Size and Forecast, By Country, 2026-2033, (USD Bn) o U.K. o Germany o Italy o France o Spain o Russia o Rest of Europe o Asia Pacific  Market Size and Forecast, By Indication, 2026-2033, (USD Bn)  Market Size and Forecast, By Product Type, 2026-2033, (USD Bn)  Market Size and Forecast, By Distribution Channel, 2026-2033, (USD Bn)  Market Size and Forecast, By Country, 2026-2033, (USD Bn) o China o Japan o India o ASEAN o Australia o South Korea o Rest of Asia Pacific o Latin America  Market Size and Forecast, By Indication, 2026-2033, (USD Bn)  Market Size and Forecast, By Product Type, 2026-2033, (USD Bn)  Market Size and Forecast, By Distribution Channel, 2026-2033, (USD Bn)  Market Size and Forecast, By Country, 2026-2033, (USD Bn) o Brazil o Mexico o Argentina o Rest of Latin America o Middle East  Market Size and Forecast, By Indication, 2026-2033, (USD Bn)  Market Size and Forecast, By Product Type, 2026-2033, (USD Bn)  Market Size and Forecast, By Distribution Channel, 2026-2033, (USD Bn)  Market Size and Forecast, By Country, 2026-2033, (USD Bn) o GCC Countries o Israel o Rest of Middle East o Africa  Market Size and Forecast, By Indication, 2026-2033, (USD Bn)  Market Size and Forecast, By Product Type, 2026-2033, (USD Bn)  Market Size and Forecast, By Distribution Channel, 2026-2033, (USD Bn)  Market Size and Forecast, By Country, 2026-2033, (USD Bn) o North Africa o Central Africa o South Africa 8. Competitive Landscape o Company Profiles  Smith & Nephew o Company Overview o Product Portfolio o Financial Performance o Recent Highlights o Strategies  Medline Industries, Inc o Company Overview o Product Portfolio o Financial Performance o Recent Highlights o Strategies  Bristol-Myers Squibb Pharma Company o Company Overview o Product Portfolio o Financial Performance o Recent Highlights o Strategies  Ciron Drugs o Company Overview o Product Portfolio o Financial Performance o Recent Highlights o Strategies  King Pharmaceuticals, Inc o Company Overview o Product Portfolio o Financial Performance o Recent Highlights o Strategies o Analyst Views 9. Section o References o Research Methodology o About us and Sales Contact

提及公司

Smith & NephewMedline Industries, IncBristol-Myers Squibb Pharma CompanyCiron DrugsKing Pharmaceuticals, Inc

同分類最新報告(醫療器材)

常見問題

這份報告可以先索取樣本嗎?

可以。建議購買前先申請樣本,提出申請後約 2 個工作天內提供,您可以先確認內容涵蓋範圍是否符合需求。

報告價格如何計算?

報告以美元標價,台幣報價依當日匯率換算並加計 5% 營業稅。不同授權版本(單人/多人/企業全站)價格不同,量子訊息會評估您的使用情境後提供最優惠報價。

下單後多久交付?如何付款?

一般 3–7 個工作天交付,實際依出版商狀況於下單前確認。收到報告確認無誤後開立台幣發票,30 天內電匯付款即可。

量子訊息有限公司為 Coherent Market Insights 在台灣的授權代理,提供報告購買、樣本申請與授權諮詢。電話 +886 2 7751 5192 ・ 聯絡我們